0001209191-21-006730.txt : 20210202 0001209191-21-006730.hdr.sgml : 20210202 20210202161157 ACCESSION NUMBER: 0001209191-21-006730 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210130 FILED AS OF DATE: 20210202 DATE AS OF CHANGE: 20210202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Walkey Carl CENTRAL INDEX KEY: 0001843189 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36327 FILM NUMBER: 21581575 MAIL ADDRESS: STREET 1: C/O NEOLEUKIN THERAPEUTICS, INC. STREET 2: 360-1616 EASTLAKE AVENUE EAST CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Neoleukin Therapeutics, Inc. CENTRAL INDEX KEY: 0001404644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SUITE 360 - 1616 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-732-2133 MAIL ADDRESS: STREET 1: SUITE 360 - 1616 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC DATE OF NAME CHANGE: 20140128 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC DATE OF NAME CHANGE: 20070626 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-30 0 0001404644 Neoleukin Therapeutics, Inc. NLTX 0001843189 Walkey Carl CO NEOLEUKIN THERAPEUTICS, INC. 360-1616 EASTLAKE AVENUE EAST SEATTLE WA 98102 0 1 0 0 Senior Vice President Stock Option (Right to Buy) 12.60 2021-01-30 4 A 0 45000 0.00 A 2031-01-30 Common Stock 45000 45000 D The option vests as to 1/4 of the total shares on January 30, 2022, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ Kris McGrew, as Attorney-in-Fact for Carl Walkey 2021-02-02